KW2871
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KW2871, covering 2018-02-09 to 2018-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma [Phase 2]